pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,210 catalysts · 7,208 phase readout · 2,441 8k filing · 386 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: approval×type: recall×clear all
type
  • phase readout7,208
  • 8k filing2,441
  • earnings386
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT07565649: Impact of Systematic Point-of-Care Ultrasound Implementation on Clinical Outcomes and Survival in Septic Shock: A Retrospective Single-Center Cohort Study

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra. Phase: . Conditions: Septic Shock, Sepsis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06092749: Chronic Unilateral Lumbar Radicular Pain

Sponsor: Ain Shams University. Phase: NA. Conditions: Neuropathic Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07376538: Response-Based Local Therapy for Regionally Advanced Breast Cancer

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Phase: PHASE2. Conditions: Breast Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07467655: THE EFFECT OF DIGITAL STORYTELLING ON NURSING STUDENTS' NURSING PROCESS EDUCATION

Sponsor: Sakarya University. Phase: NA. Conditions: Education, Nursing, Students, Nursing, Clinical Competence, Clinical Decision-Making in Nursing, Evidence-Based Practice

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT04430426: Heterozygous Individuals for AGXT and Kidney Stones

Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Kidney Stone, Urolithiasis, Calcium Oxalate

full page →ctgov ↗
›RECRUITINGphase readoutNCT07776626: Phase I Exploratory Study of YOLT-203 in Patients With Primary Hyperoxaluria Type 1 (PH1)

Sponsor: YolTech Therapeutics Co., Ltd. Phase: PHASE1. Conditions: Primary Hyperoxaluria Type 1, PH1

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07484126: A Retrospective Clinical Study of Metabolic Status and Response to Nutritional Therapy in Patients With Mechanical Ventilation

Sponsor: Southeast University, China. Phase: . Conditions: Mechanical Ventilation

full page →ctgov ↗
›RECRUITINGphase readoutNCT07693426: Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents

Sponsor: Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.. Phase: PHASE1. Conditions: Adolescence Obesity

full page →ctgov ↗
›COMPLETEDphase readoutNCT07016178: Innovative Cognitive Impairment Case Finding and Engagement for Diverse Participation in Alzheimer's Disease Care, Treatment, And Research

Sponsor: Indiana University. Phase: NA. Conditions: Mild Cognitive Impairment (MCI), Alzheimer Disease, Alzheimer's Disease (Incl Subtypes), Dementia, Cognitive Decline

full page →ctgov ↗
›COMPLETEDphase readoutNCT04761185: Raltitrexed in HIPEC

Sponsor: Fudan University. Phase: PHASE1. Conditions: Colorectal Cancer, Raltitrexed, HIPEC

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07562685: Effect of Knee and Heel Off-Loader Brace With Non Weight Bearing Strength in Knee Osteoarthritis

Sponsor: Lahore University of Biological and Applied Sciences. Phase: NA. Conditions: Knee Osteoarthristis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06816485: INFLATE Study: Investigation of the Safety and Performance of a Novel PTV Balloon in Patients Undergoing TAVI for Severe Aortic Stenosis

Sponsor: Biosensors Europe SA. Phase: NA. Conditions: Aortic Diseases

full page →ctgov ↗
›RECRUITINGphase readoutNCT06576635: LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC) Metastatic Patients

Sponsor: University of Illinois at Chicago. Phase: NA. Conditions: NSCLC

full page →ctgov ↗
›RECRUITINGphase readoutNCT07006935: REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health)

Sponsor: Case Western Reserve University. Phase: NA. Conditions: Schizophrenia, Schizo Affective Disorder, Schizophreniform Disorders

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07745335: AVE-Neurofeedback for Academic Anxiety and Divergent Thinking

Sponsor: Daniswara Raditya Suprapto. Phase: NA. Conditions: Academic Anxiety, Test Anxiety, Divergent Thinking

full page →ctgov ↗
›COMPLETEDphase readoutNCT05176808: Telehealth Parent-Implemented Intervention for Young Children With Autism Spectrum Disorder (ASD)

Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.. Phase: NA. Conditions: Autism Spectrum Disorder, Autistic Disorder, Active Autistic Disorder, Autism, Asperger Syndrome, PDD-NOS, Social Communication Delay, Mixed Expressive Receptive Language Disorder, Other Symbolic Dysfunctions

full page →ctgov ↗
›COMPLETEDphase readoutNCT05734508: Assessment of Safety Profile of MVA-BN Vaccine in the PALM-007 Study in DRC

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE4. Conditions: Monkeypox

full page →ctgov ↗
›RECRUITINGphase readoutNCT06610266: Efficacy and Safety of Weifuchun Tablet in Reversing Gastric Intestinal Metaplasia

Sponsor: Yongquan Shi. Phase: PHASE4. Conditions: Gastric Intestinal Metaplasia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07660666: Feasibility of an Enhanced Symptom Monitoring and Expedited Subspecialty Care Referral Intervention to Improve Side Effect Management for Patients With Melanoma Receiving an Immune Checkpoint Inhibitor

Sponsor: OHSU Knight Cancer Institute. Phase: NA. Conditions: Melanoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07583056: EEG Prediction and Clinical Efficacy of tDCS in Fibromyalgia.

Sponsor: Ionclinics & Deionic SL. Phase: NA. Conditions: Fibromyalgia (FM)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07553429: A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Diabetic Macular Edema

full page →ctgov ↗
›RECRUITINGphase readoutNCT05830929: Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female Cancer Patients

Sponsor: Chinese University of Hong Kong. Phase: NA. Conditions: Neoplasms

full page →ctgov ↗
›COMPLETEDphase readoutNCT06186102: Polyamine Treatment in Elderly Patients With Coronary Artery Disease

Sponsor: University of Aarhus. Phase: PHASE2. Conditions: Ischemic Heart Disease, Myocardial Infarction, Cardiovascular Diseases, Hypertensive Heart Disease, Hypertension, Diastolic Dysfunction, Obesity, Metabolic Syndrome, Diabetes Mellitus, Type 2, Dietary Habits, Inflammation, Quality of Life, Cognition Disorder, Cognitive Impairment

full page →ctgov ↗
›COMPLETEDphase readoutNCT04756453: The Effect of Clip-traction on ESD Resection Time.

Sponsor: Karolinska Institutet. Phase: NA. Conditions: Adenoma Colon

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06919653: Promoting Adherence to Chemotherapy Handling Guidelines Among Oncology Nurses

Sponsor: University of Cincinnati. Phase: NA. Conditions: Chemotherapy Exposure, Handling Guidelines, Oncology Nurse, Adherence

full page →ctgov ↗
›COMPLETEDphase readoutNCT05766072: Early Intervention Coping Kids (TIM) Follow up Study

Sponsor: University of Oslo. Phase: NA. Conditions: Anxiety Disorders, Depression

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07634172: Diagnosis and Treatment of Late Neurological Ischemic Deficit in Patients Suffering From Subarachnoid Hemorrhage.

Sponsor: Société Française d'Anesthésie et de Réanimation. Phase: . Conditions: Aneurysmal Subarachnoid Haemorrhage, Delayed Ischemic Neurological Deficit

full page →ctgov ↗
›COMPLETEDphase readoutNCT03251495: Immunologic Responses to a Live Attenuated Oral Cholera Vaccine

Sponsor: Emory University. Phase: PHASE2. Conditions: Cholera

full page →ctgov ↗
›RECRUITINGphase readoutNCT05857995: Precision Lung Cancer Survivorship Care Intervention

Sponsor: Jerod L Stapleton, PhD. Phase: NA. Conditions: Lung Cancer, Pulmonary Neoplasm, Neoplasms, Lung, Neoplasms, Pulmonary, Neoplasm, Pulmonary, Cancer, Lung, Cancers, Lung, Pulmonary Cancer, Cancer, Pulmonary, Cancers, Pulmonary, Pulmonary Cancers, Cancer of the Lung, Cancer of Lung, Pulmonary Neoplasms, Lung Cancers

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04005339: NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer

Sponsor: Georgetown University. Phase: PHASE2. Conditions: Advanced Biliary Tract Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07367139: Occupational Exposure to Whole Body Vibration Among U.S. Military Veterans: Acute and Chronic Contributions to Musculoskeletal Disorders and Spine-Area Pain

Sponsor: Milwaukee VA Medical Center. Phase: NA. Conditions: Spine Health, Spine Injuries and Disorders, Spine Degeneration, Whole Body Vibration

full page →ctgov ↗
›RECRUITINGphase readoutNCT07278739: Testing an Educational Program to Improve Goals of Care Conversations Between Patients and Their Care Teams

Sponsor: SWOG Cancer Research Network. Phase: NA. Conditions: Malignant Solid Neoplasm

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07782177: Optimizing Elderly Hearing Loss Care in Hong Kong A Cost-Effectiveness and Satisfactory Analysis of a Pilot Collaborative Model Between Otorhinolaryngologists and Family Medicine Specialists

Sponsor: Tseung Kwan O Hospital, Hong Kong. Phase: . Conditions: Hearing Loss, Age-Related, Presbycusis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07350577: Evaluate the Safety, Tolerability, PK and PD of SAD of Intravenously Adminsterted ALTB-268 in Healthy Participants

Sponsor: AltruBio Inc.. Phase: PHASE1. Conditions: Ulcerative Colitis (UC)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07442175: Blood Pressure Monitor (TH-75) Atrial Fibrillation Detection Function Clinical Trial

Sponsor: Andon Health Co., Ltd. Phase: . Conditions: Atrial Fibrillation (AF)

full page →ctgov ↗
›COMPLETEDphase readoutNCT06127901: Prevalence and Risk Factors for Postoperative Delirium 48 Hours After Surgery

Sponsor: Fundacin Biomedica Galicia Sur. Phase: . Conditions: Postoperative Delirium

full page →ctgov ↗
›COMPLETEDphase readoutNCT06352801: Effectiveness of Self-Compassion Intervention on Enhancing Self-Compassion and Psychological Well-Being of Children With Attention Deficit/Hyperactivity Disorder

Sponsor: The University of Hong Kong. Phase: NA. Conditions: ADHD, Self-Compassion, Psychological Well-Being

full page →ctgov ↗
›RECRUITINGphase readoutNCT07585357: Adaptive Mobile Interventions to Reduce Cancer Risk Behaviors

Sponsor: Johns Hopkins Bloomberg School of Public Health. Phase: NA. Conditions: Smoking Cessation

full page →ctgov ↗
›RECRUITINGphase readoutNCT06959901: PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents

Sponsor: Baylor College of Medicine. Phase: NA. Conditions: Obesity and Diabetes Mellitus, Type 2, Diabetes Prevention

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07546201: Investigation of Imagery Abilities in Individuals With Migraine

Sponsor: Hacettepe University. Phase: . Conditions: Migraine, Healthy Participants

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07478575: Effects of SGLT2 Inhibitors on Erythropoiesis in Heart Failure

Sponsor: University Medical Centre Ljubljana. Phase: . Conditions: Heart Failure, Anemia, Renal Insufficiency

full page →ctgov ↗
›TERMINATEDphase readoutNCT04673175: Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation

Sponsor: Weill Medical College of Cornell University. Phase: PHASE4. Conditions: Pneumonia, Hematologic Malignancy, Pseudomonas Aeruginosa Infection, Bacteremia, Hematopoietic Stem Cell Transplant (HSCT)

full page →ctgov ↗
›COMPLETEDphase readoutNCT01891812: Nitrous Oxide Analgesia Vaso-occlusive Crisis

Sponsor: Columbia University. Phase: PHASE2. Conditions: Sickle Cell Disease, Vaso-occlusive Crisis

full page →ctgov ↗
›RECRUITINGphase readoutNCT05096481: PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Sponsor: Nationwide Children's Hospital. Phase: PHASE2. Conditions: High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Recurrent Medulloblastoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT05776381: The Impact of a Patient Decision Aid on Treatment Choices for Patients With an Unexpected Malignant Colorectal Polyp

Sponsor: Vejle Hospital. Phase: PHASE2. Conditions: Shared Decision Making, Colonic Polyp, Decision Aids, Rectal Polyp, Colorectal Polyp, Colorectal Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT03169881: Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants

Sponsor: NICHD Neonatal Research Network. Phase: PHASE3. Conditions: Neurocognitive, Neuroprotective, Neonatal, Neurodevelopmental Impairment

full page →ctgov ↗
›RECRUITINGphase readoutNCT02391519: Effects of High Altitude on AMPK Activation

Sponsor: University of Colorado, Denver. Phase: . Conditions: Pregnancy, IUGR, Preeclampsia

full page →ctgov ↗
›RECRUITINGphase readoutNCT04752319: BreEStim for Motor Recovery in Chronic Stroke With Moderate Impairment After a Long-term Use (Pilot).

Sponsor: The University of Texas Health Science Center, Houston. Phase: NA. Conditions: Motor Recovery

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07588919: Sciatic Neural Mobilization in Lumbar-Related Leg Pain

Sponsor: Istinye University. Phase: NA. Conditions: Low Back Pain, Leg Pain and/or Back Pain

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04375228: Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs)

Sponsor: Columbia University. Phase: PHASE2. Conditions: Immune-related Adverse Events, Advanced Solid Tumor

full page →ctgov ↗
← prev
page 143 of 145
next →